Filing Flows › RxSight (RXST) › Who owns the stock
Who owns RxSight (RXST) stock
142 funds reported RxSight (RXST) shares in their latest 13F filings, worth $221M in all. The largest holder is BlackRock ($27.9M). Last quarter 87 funds added to their stakes and 62 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| BlackRock | 5,790,408 | $27.9M | increase | 2026-06-30 |
| Vanguard Group | 2,229,539 | $23.2M | increase | 2025-12-31 |
| Millennium Management LLC | 3,030,287 | $14.6M | increase | 2026-06-30 |
| No Street GP LP | 2,055,000 | $9.9M | increase | 2026-06-30 |
| Nomura Holdings | 2,000,060 | $9.6M | unchanged | 2026-06-30 |
| D. E. Shaw | 1,985,215 | $9.6M | increase | 2026-06-30 |
| Vanguard Capital Management LLC | 1,675,582 | $8.1M | decrease | 2026-06-30 |
| AQR Capital Management LLC | 1,533,826 | $7.4M | increase | 2026-06-30 |
| Acadian Asset Management LLC | 1,501,180 | $7.2M | increase | 2026-06-30 |
| Federated Hermes | 1,201,195 | $5.8M | increase | 2026-06-30 |
| Two Sigma Investments, LP | 1,147,048 | $5.5M | decrease | 2026-06-30 |
| Healthcare of Ontario Pension Plan Trust Fund | 1,131,400 | $5.5M | unchanged | 2026-06-30 |
| UBS Group AG | 1,016,066 | $4.9M | increase | 2026-06-30 |
| Jacobs Levy Equity Management | 998,569 | $4.8M | decrease | 2026-06-30 |
| Marshall Wace, LLP | 995,916 | $4.8M | increase | 2026-06-30 |
RxSight's latest quarter
RxSight, Q3 2026: revenue $24.6M (-19% year over year), operating margin -75.3%, net loss $16.2M, operating cash flow $45.2M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most RXST stock?
By the latest 13F filings: BlackRock ($27.9M); Vanguard Group ($23.2M); Millennium Management LLC ($14.6M); No Street GP LP ($9.9M); Nomura Holdings ($9.6M).
What is the short interest in RXST?
4,118,769 shares were sold short at the 2026-10-15 settlement, 0.75% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.